< Back to search
Filter
1

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

for
B-cell Non-Hodgkin Lymphoma
Location: New York NY, Jacksonville FL, Franklin TN, Rochester MN
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07123454

Phase1, Phase2, Recruiting

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Scarborough ME, Boston MA
Sponsor: Inhye Ahn

Sex: All

Age: 18+

Code: NCT06333262

Phase2, Recruiting

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

for
T-cell Lymphoma, Graft Versus Host Disease, Lymphoma, T-Cell,
Location: Columbus OH
Sponsor: Jonathan Brammer

Sex: All

Age: 18+

Code: NCT07356245

Phase2, Recruiting

Survivors Uniting for Remote Guided Exercise

for
Cancer,
Location: Fort Collins CO
Sponsor: Colorado State University

Sex: All

Age: 18+

Code: NCT07290309

Recruiting

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Newnan GA, Irvine CA, Duarte CA, Long Beach CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07218510

Phase2, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Hackensack NJ, Norfolk VA, Durham NC, Buffalo NY,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase3, Recruiting

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Boston MA, Chapel Hill NC, Pittsburgh PA, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061951

Phase2, Recruiting

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

for
Multiple Myeloma, Hodgkin Lymphoma, Non-hodgkin Lymphoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT07188090

Phase2, Recruiting

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

for
Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07231952

Phase2, Recruiting

xDRIVE for Florida-based Cancer Patients

for
Cancer, Neoplams, Refractory, Recurrence, Leukaemia, Lymphoma,
Location: Miami FL
Sponsor: First Ascent Biomedical Inc.

Sex: All

Age: 0+

Code: NCT07167381

Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

for
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia,
Location: Dallas TX, Salt Lake City UT
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 0+

Code: NCT06357754

Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase1, Phase2, Recruiting

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for
Lymphoma
Location: Stony Brook NY, Philadelphia PA, Orlando FL, Chicago IL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06624085

Phase1, Recruiting

Tissue Repository: CTCL Collection Protocol

for
Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis,
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT02840747

Recruiting

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

for
Folliculotropic Mycosis Fungoides,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04930653

Phase2, Recruiting

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

for
Follicular Lymphoma, Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06108232

Phase2, Recruiting

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

for
Mantle Cell Lymphoma, Lymphoma
Location: Boston MA, New York NY, St Louis MO
Sponsor: Christine Ryan

Sex: All

Age: 18+

Code: NCT06854003

Phase2, Recruiting

Two Step Haplo With Radiation Conditioning

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Philadephia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT05031897

Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase3, Recruiting

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Durham NC, Kansas City MO, Seattle WA, San Francisco CA
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT06520098

Phase2, Recruiting